Journal of the American College of Cardiology

Article	Citations
PROPER USE OF CHRONIC TOTAL OCCLUSIONS (CTO) HYBRID ALGORITHM TO SECURE LEFT MAIN DISSECTION	1690
A RARE CASE OF CHONDROSARCOMA WITH CARDIAC METASTASIS	1344
CARDIAC MASS IN A PATIENT WITH RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA WITH NONDIFFUSE BONE MARROW INVOLVEMENT	1017
ASSOCIATION OF AGE WITH ORAL ANTICOAGULANT PRESCRIPTION AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM A UNITED STATES COMMERCIAL CLAIMS DATABASE	746
CORONARY FLOW RESERVE AND STRESS MYOCARDIAL BLOOD FLOW ACROSS THE SPECTRUM OF AORTIC STENOSIS	632
TCTAP A-075 Effects of Silver Nanoparticles in Isoproterenol-Induced Myocardial Infarction	554
SHINGLE-VACCINE ASSOCIATED MYOCARDITIS-A CASE REPORT	478
DOUBLE TROUBLE: NEW ONSET DYNAMIC LVOT OBSTRUCTION AFTER TAVR	433
AFRICAN AMERICAN WITH ATRIAL FIBRILLATION (AF) AND HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) ARE AT HIGHER RISK OF MORTALITY	405
PERCUTANEOUS CORONARY INTERVENTION OUTCOMES IN PATIENTS WITH LIVER CIRRHOSIS A META ANALYSIS	403
TCTAP C-022 Shock the Rock- Intravascular Lithotripsy Assisted PCI of an Extremely Calcific Right Coronary Artery	353
THE GREAT MIMICKER: IMMUNE CHECKPOINT INHIBITOR INDUCED MYOCARDITIS	348
GEOGRAPHIC DISTRIBUTION AND CLINICAL OUTCOMES AMONG PATIENTS WITH TRANSCATHETER MITRAL VALVE REPAIR IN THE UNITED STATES	341
LONG-TERM OUTCOMES OF HEART TRANSPLANTATION AND LEFT VENTRICULAR ASSIST DEVICES IN PATIENTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS: A SYSTEMATIC REVIEW AND META-ANALYSIS	335
PLASMA DESMOSINE, A BIOMARKER OF ELASTIN DEGRADATION, PREDICTS OUTCOMES IN ACUTE MYOCARDIAL INFARCTION	306
TCTAP C-172 Case Report: Refractory Chest Pain After Transcatheter Aortic Valve Implantation	306
Full Issue PDF	304
THE JAILED SINOATRIAL NODE: SINUS ARREST-INDUCED CARDIOGENIC SHOCK FOLLOWING PERCUTANEOUS INTERVENTION	281
RATE AND CAUSES OF 30-DAY READMISSION AFTER IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PLACEMENT: ANALYSIS OF NATIONAL INPATIENT SAMPLE	279
PHARMACOLOGICAL INHIBITION OF BAG3-HSP70 WITH THE PROPOSED CANCER THERAPEUTIC JG-98 IS TOXIC FOR CARDIOMYOCYTES: IN-VIVO PILOT STUDY	267
DERIVATION AND VALIDATION OF A RISK STRATIFICATION TOOL IN PATIENTS WITH TYPE 2 MYOCARDIAL INFARCTION	266
CARDIAC MYXOMAS: CLINICAL CHARACTERISTICS AND OUTCOMES FROM A HIGH-VOLUME CENTER	263
CAUGHT IN THE ACT: MINOCA IN A PATIENT WITH SEVERE CORONARY VASOSPASM	254
THE EFFECTS OF EMPAGLIFLOZIN AND ORAL KETONE ESTER ON CARDIAC FUNCTION, STRUCTURE, AND METABOLISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION	254
PATIENT-REPORTED OUTCOMES IN CLINICAL STUDIES OF PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES	237

NON-INVASIVE ASSESSMENT OF MYOCARDIAL ENERGETICS USING 11-C ACETATE POSITRON EMISSION TOMOGRAPHY: SYSTEMATIC REVIEW AND META-ANALYSIS	227
THE ASSOCIATION OF ATRIAL UPTAKE AND ATRIAL FIBRILLATION IN PATIENTS WITH SUSPECTED CARDIAC AMYLOIDOSIS	223
ANOMALOUS ORIGIN AND PRESENTATION: A GIANT CORONARY ANEURYSM CAUSING CHEST PAIN	210
IMPACT OF MALNUTRITION BY GERIATRIC NUTRITIONAL RISK INDEX IN ELDER PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICE: AN INTERMACS ANALYSIS	200
ACUTE MYOCARDIAL INJURY (AMI) MIMICKING ACUTE CORONARY SYNDROME (ACS) IN THE SETTING OF METHANOL TOXICITY	200
SEA ANEMONE TUMOR OF THE AORTA PRESENTING WITH DYSPNEA IN A WOMAN	186
TCTAP C-180 Atrial Septal Defect With Desaturation in an Elderly Patient : Need to Closed	178
PAPILLARY MUSCLE ABNORMALITY AS AN ELECTROCARDIOGRAPHIC MIMICKER OF APICAL HYPERTROPHIC CARDIOMYOPATHY	166
REAL-WORLD PERFORMANCE AND VALIDATION OF THE ARTIFICIAL INTELLIGENCE ENHANCED ELECTROCARDIOGRAM FOR THE DETECTION OF AMYLOIDOSIS	165
TCTAP C-183 Device-Related Hemolytic Anemia After Transcatheter Closure of a Ruptured Ventricular Septum: To Wait or to Act?	165
TCTAP C-189 A Challenging Case Report: Transcatheter Occulsion One Coronary Artery Fistula From Right Coronary Artery to Left Ventricule	164
IS SYSTOLIC AND DIASTOLIC FUNCTION INCLUDING GLOBAL LONGITUDINAL STRAIN BY ECHOCARDIOGRAPHY COMPROMISED IN ADULT PATIENTS TREATED WITH CD19 CAR T-CELL THERAPIES FOR HEMATOLOGICAL MALIGNANCIES IN THOSE	163
EOSINOPHILIC MYOCARDITIS AND LOEFFLER ENDOCARDITIS IN THE SETTING OF HYPEREOSINOPHILIC SYNDROME: DEMOGRAPHICS, CARDIAC IMAGING, MANAGEMENT AND OUTCOMES	162
GENDER DISPARITY IN CLINICAL OUTCOMES IN PATIENTS WITH TAKOTSUBO CARDIOMYOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS.	161
ECHOCARDIOGRAPHIC EPICARDIAL FAT THICKNESS AS A PREDICTOR FOR RECURRENCE OF PREGNANCY-INDUCED HYPERTENSION IN EGYPTIANS	159
CLINICAL CHARACTERISTICS, EVALUATION AND OUTCOMES OF CHYLOPERICARDIUM: A SYSTEMATIC REVIEW	156
DEVELOPMENT AND VALIDATION OF AN OUTCOME PREDICTION MODEL FOR REPAIRED TETRALOGY OF FALLOT: THE INDICATOR COHORT	154
DIAGNOSING CONGENITAL HEART DISEASE AT 63 YEARS OLD	150
ANOMALOUS LEFT CORONARY ARTERY ARISING FROM THE PULMONARY ARTERY (ALCAPA) WITH AN INTRAMURAL AORTIC COURSE: A RARE VARIANT OF A RARE ANOMALY PRESENTS AN IMAGING CHALLENGE	150
SYSTEMIC RV FAILURE WITH SEPTAL BOWING AS A CAUSE OF SAM IN D-TRANSPOSITION OF THE GREAT ARTERIES	147
ASSOCIATION OF TRANSTHYRETIN VAL122ILE VARIANT WITH INCIDENT HEART FAILURE AND MORTALITY AMONG BLACK AMERICANS	146
IMPACT OF RELATIVE TEE GASTROESOPHAGEAL CONTRAINDICATIONS ON OUTCOMES IN HOSPITALIZATION UNDERGOING TEE	146
TCT-37 Impact of Bleeding During Dual Antiplatelet Treatment on Long-Term Prognosis in Patients Undergoing Percutaneous Coronary Intervention	146
TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized Studies	143
IDIOPATHIC MASSIVE CORONARY ECTASIA IN THE SETTING OF AN ACUTE CORONARY SYNDROME	143
EXTREMELY LARGE AORTIC ANNULUS TAVR USING OVER-EXPANDED EDWARDS SAPIEN 3 VALVE WITH RENAL FUNCTION AND FUNCTIONAL CLASS IMPROVEMENT AFTER THE PROCEDURE.	141
SCALABLE DIGITAL SOLUTIONS TO ADDRESS PATIENT-CENTERED AMBULATORY CARDIOVASCULAR CARE IN THE GREATER ROCHESTER REGION	141
COMPLICATIONS AND FAILURE MODES OF THE TURNPIKE CATHETERS: INSIGHTS FROM MAUDE DATABASE	140
PREDICTORS OF ARRHYTHMIA RECURRENCE AFTER CATHETER ABLATION OF ATRIAL FIBRILLATION IN ELDERLY PATIENTS	138
IMPACT OF IN-HOSPITAL BLEEDING EVENTS ON MORTALITY IN STEMI PATIENTS WITH RADIAL PCI	137
STAGES OF CHRONIC KIDNEY DISEASE AND POST-PCI IN-HOSPITAL MORTALITY AMONG 6,884 PATIENTS ENTIRE SPECTRUM OF CORONARY ARTERY DISEASE PRESENTATION	135
TCTAP C-143 Mesenteric Venous Thrombosis With Abdominal Compartment Syndrome	135
TCT-90 Predictors of Device-Related Complications in Elderly Patients Requiring Mechanical Circulatory Support for Cardiogenic Shock Due to Acute Coronary Syndrome	133
MORTALITY TRENDS IN HEART FAILURE AND DIFFERENCES BY RACE AND SEX IN THE UNITED STATES: 1999 - 2019	131
HIDDEN VULNERABILITIES: THE USE OF OPTICAL COHERENCE TOMOGRAPHY FOR DELINEATION OF CULPRIT LESIONS IN MYOCARDIAL INFARCTION	130
A COMPLEX CASE OF FISTULOUS TRACT BETWEEN LEFT ANTERIOR DESCENDING ARTERY AND PULMONARY ARTERY	129
ASPIRIN-MEDIATED LYSINE ACETYLATION ALTERS SARCOMERIC MECHANICAL PROPERTIES IN CARDIOMYOCYTES	129
TCT-32 ABSTRACT WITHDRAWN	129
HEART-ENRICHED LONG NONCODING RNA NPPA-AS1 REGULATES PATHOLOGICAL CARDIAC HYPERTROPHY BY INITIATING A EP300-GATA4 AXIS	128
TCT-34 Hemoglobin Drop in the Absence of Overt Bleeding After Percutaneous Coronary Intervention is Associated With In-Hospital Mortality	127
REGIONAL HETEROGENEITY OF EXERCISE-INDUCED CITED4 EXPRESSION IS SPATIALLY LINKED WITH CARDIAC MICROSTRUCTURAL REMODELING CHARACTERIZED BY DIFFUSION TENSOR CARDIAC MAGNETIC RESONANCE	127
STROKE RISK IN HEART FAILURE AND ATRIAL FIBRILLATION - DOES EJECTION FRACTION MATTER?	125
A MASS-IVE MYSTERY: MULTIMODALITY IMPACT ON PATIENT OUTCOMES	125
GENDER DIFFERENCES IN REFERRAL PATTERNS FOR EVALUATION OF STABLE CORONARY ARTERY DISEASE (CAD) BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (CCTA)	125
TCT-307 In Vivo Characterization of Coronary Plaques: Findings From a Novel Hybrid Intravascular Ultrasound-Optical Coherence Tomography Intracoronary Imaging System	125
A LARGE SINGLE TRANSMURAL CARDIAC RHABDOMYOMA IN A FETUS	123
IS SACUBITRIL/VALSARTAN LESS LIKELY TO BE PRESCRIBED IN ELDERLY PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION? A ROOT CAUSE ANALYSIS	123
SUB-CLINICAL RIGHT VENTRICULAR DYSFUNCTION IN COVID-19 PATIENTS	123
ADVANCED HEART FAILURE CHARACTERISTICS AND OUTCOMES IN PRIVATELY INSURED U.S. ADULTS	122
TCTAP C-160 Optical Coherence Tomography Guided Percutaneous Coronary Intervention of Spontaneous Recanalized Coronary Thrombus	122

A SUBTLE CASE OF CARDIAC AMYLOIDOSIS	119
COMBINING SERUM PROTEOMIC WITH METABOLOMIC SEQUENCING TECHNOLOGY TO EXPLORE METABOLIC PATHWAYS RELATED TO CORONARY ARTERY DISEASE	118
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER	117
ISCHEMIA INDUCED BY A GIANT RIGHT CORONARY ARTERY ANEURYSM	117
MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES (MINOCA) MIMICKERS IN ST-ELEVATION MYOCARDIAL INFARCTION	116
MATERNAL CARDIAC EVENTS AMONG PREGNANT WOMEN WITH M-WHO CLASS III AND IV AT THE FIRST CARDIO-OBSTETRIC CLINIC IN IRAQ	115
TCT-169 Spontaneous Coronary Artery Dissection in Patients With and Without Chronic Systemic Inflammatory Diseases	114
2D ECHOCARDIOGRAPHY IS SENSITIVE BUT NOT SPECIFIC FOR LEFT VENTRICULAR HYPERTROPHY IN HFPEF: COMPARISON WITH 3D ECHOCARDIOGRAPHY	113
UNEXPLAINED LEFT VENTRICULAR DYSFUNCTION: HOW IS CORONARY ANGIOGRAPHY USEFUL TODAY?	113
TCT-427 Renal Denervation Improves Renal Hemodynamic Status in Patients With Diabetes With Resistant Hypertension and Chronic Kidney Disease	112
TCT-467 Protein-Energy Malnutrition Is Associated With Cardiac Arrest and a Longer Hospital Length of Stay in Patients Admitted With Transcatheter Mitral Valve Repair	112
LEFT VENTRICLE BIOMECHANICS IN CLASSIC VERSUS LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS: TRANSLATIONAL APPLICATION OF COMPUTATIONAL MODELING	111
NATIONWIDE TRENDS OF BALLOON PULMONARY ANGIOPLASTY AND PULMONARY THROMBOENDARTERECTOMY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	111
THREE TIME LOSER OR THIRD TIME’S THE CHARM? OUTCOME OF REPEATED PERCUTANEOUS CORONARY INTERVENTION FOR RECURRENT RESTENOSIS AFTER TWO LAYERS OF DRUG-ELUTING STENTS	110
TCT-415 Predictors of New-Onset Atrial Fibrillation Following Transcatheter Mitral Valve Repair: Insights From the Nationwide Readmissions Database	109
TCT-362 Comparison of Radial Versus Femoral Arterial Access for Complex Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis	109
TCT-229 Impact of Coronary CT Image Quality on the Accuracy of the FFRCT Planner to Predict Fractional Flow Reserve After PCI	108
TCT-263 Impact of MitraClip NT and XTW on Pressure Gradient	107
TCT-244 Impact of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization	107
TCT-264 Role of Renal Denervation in Hypertension: An Updated Meta-Analysis of Randomized Sham Controlled Trials	106
TCT-323 Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a Na	103
CLEARED SARS-COV-2 INFECTION IS ASSOCIATED WITH LOWER RISK PULMONARY EMBOLISM	100
TCT-326 In Vitro Performance of Thermoformed Polymeric Transcatheter Heart Valves	100
COLCHICINE ISN’T ALWAYS THE ANSWER!	100
USE OF SHAPE-HF SYSTEM FOR POINT-OF-CARE CARDIOPULMONARY EXERCISE TESTING OF PATIENTS WITH CTEPH AND CTED; A PRELIMINARY ANALYSIS	99
IMPACT OF INTERHOSPITAL TRANSFER ON OUTCOMES IN ACUTE PULMONARY EMBOLISM	99
TCT-294 A Novel Risk Score to Identify AF Patients Undergoing PCI at High Thrombotic Risk a RE-DUAL PCI Secondary Analysis	97
TCT-27 Abstract Withdrawn	97
TCT-302 Optical Coherence Tomography–Derived Changes in Plaque Structural Stress Over the Cardiac Cycle: A New Method for Plaque Biomechanical Assessment	96
TCT-207 First Experience With the Novel Selution SLR Sirolimus-Eluting Balloon in All-Comer Patients Presenting With Acute and Chronic Coronary Artery Disease	96
Contents	94
Long-Duration Space Flight and Cardiac Morphology	93
Reply	92
Chest Compression-Only Cardiopulmonary Resuscitation in Pediatric Out-of-Hospital Cardiac Arrest	92
Reply	92
Contents	92
Contents	91
Hypertrophic Cardiomyopathy in the General Population	91
Lipoprotein(a) Cholesterol Masquerading as Low-Density Lipoprotein Cholesterol	91
Reply	90
Game Theory, Health Care, and Economics	89
Contents	89
Cardiac Arrest and Sudden Death	89
Another Road to Rome	88
Audio Summary	87
Correction	86
The Lancet–JACC Collaboration	86
The Pathogenetic Link Between Ozone Pollution and Cardiovascular Disease	85
Contents	85
Audio Summary	85
TCT-395 Differences in Outcomes Between Rutherford 4 and Rutherford 5/6 Patients Undergoing Endovascular Intervention for Lower Extremity Peripheral Artery Disease	84
Contents	84
TCT-419 Comparative Clinical Outcomes of Amphilimus-Eluting Stents in Diabetic vs Nondiabetic Patients	84
TCT-731 Long-Term Outcome of Left Main PCI According to Stenting Technique: 15-Year Real-World Single-Center Experience	81
TCT-509 Predictors of Stent Under Expansion in the CALIPSO Trial	81
TCT-723 Urgent TEER in 5,428 Patients With Severe Mitral Regurgitation and Cardiogenic Shock: A Systematic Review and Meta-Analysis	81
Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease	81
TCT-613 Comparison of Histology-Trained Deep Learning Approach With Human Expert Analysts for Automated Plaque Component Classification in Hybrid Intravascular Ultrasound-Optical Coherence Tomography	81
TCT-758 Clinical Outcomes of COVID-19 In Patients With Heart Failure With Reduced Ejection Fraction: Insights From National Inpatient Sample Database	79
TCT-586 First-in-Human Experience With the Percutaneous Synchronized Cardiac Assist (PSCA) System: Extravascular Mechanical Circulatory Support	79
TCT-752 Combined Valvular and Subvalvular Intervention With Innovalve TMVR Facilitates Reverse Remodeling and Improves Left Ventricular Ejection Fraction in Patients With Severe Chronic Mitral Regurgi	79
TCT-463 Microcirculatory Status After Intravascular Lithotripsy: The Marvel Study	79
TCT-251 Practice Patterns and Percutaneous Coronary Intervention Outcomes in University Hospitals: A Comparison Between Sweden and the U.S.	78
TCT-39 Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent	77
TCT-471 Sex-Specific Predictors of Adverse Events in Patients Treated With Advanced Mechanical Circulatory Support	77
TCT-911 Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes	76
TCT-533 Retrospective Comparison of Device Utilization for Left Atrial Appendage Occlusion: Amulet vs. Watchman	76
TCT-226 Validation of Coronary Angiography–Based FFR Compared With Pressure Wire–Based FFR to Guide Revascularization of Intermediate Coronary Lesions in Nonculprit Vessels in Patients Presenting With	76
TCT-949 Long-Term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study	76
TCT-163 Self-Expandable vs Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation	76
TCT-819 Impact of Sodium-Glucose Co-Transporter Inhibitors on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis	76
TCT-990 Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After Radiotherapy for Breast Cancer: The CLARIFIER: A Gender-Based Preventive Medicine Study	75
TCT-269 Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis	75
TCT-290 Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the Registry	74
TCT-493 Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials	74
TCT-442 Tissue Characteristics Can Predict Clinical Outcome in Stent-Less Percutaneous Coronary Intervention With Directional Coronary Atherectomy Followed by Drug-Coated Balloon: Insights From Histol	74
TCT-183 Periprocedural Continuation vs Interruption of Oral Anticoagulation During Transcatheter Aortic Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis	74
TCT-64 Left Atrial Appendage Closure: What Is Fabric Edge Leak and How to Treat it?	74
TCT-151 First-in-Human Study of Novel Cerebral Protection in TAVR: An Alternative to Filter-Based Protection	73
TCT-824 Transcatheter Aortic Valve Implantation on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment	73

TCT-112 Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy	73
TCT-583 Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study	72
TCT-480 Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program	72
TCT-338 “Tip in/Rendez-vous” Technique in Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS CTO Registry	72
TCT-200 Artificial Intelligence Detection of Retrograde Coronary Flow	72
TCT-303 The Role of Quantitative Calcific Assessment in Prognosis of Procedural Events in TAVR	72
TCT-570 Deep Learning-Enabled Assessment of Right Ventricular Function Using 2D Echocardiograms Improves 1-Year Mortality Prediction in Patients With Severe Mitral Regurgitation Undergoing Transcathet	71
TCT-575 Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: 24-Month Clinical Outcomes in First 100 Patients	71
TCT-387 TAVI-PREP: A Deep Learning-Based Tool for Automated Measurements Extraction in TAVR Planning	71
TCT-517 Optimal Minimal Stent Area Criteria for Long-Term Clinical Outcomes in Provisional Simple Cross-over Stenting for Left Main Bifurcation Stenosis	71
TCT-468 Outcomes of Early Coronary Reperfusion After Resuscitated Out-of-Hospital Cardiac Arrest	71
TCT-770 Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry	71
TCT-446 Thou Shall Pass! A Modified Technique With 100% Successful First-Attempt Crossover From IVC to Aorta in Transcaval TAVR	71
TCT-117 Performance and Safety of the Resorbable Magnesium Scaffold, Magmaris, in a Real-World Setting: Primary and Secondary Endpoint Analysis of the Full Cohort (2,066 Subjects) of the BIOSOLVE-IV R	70
TCT-290 Relationship Between Cardiac Computed Tomography-Derived Coronary Artery Volume and Myocardial Mass in Severe Coronary Artery Disease Population	70
TCT-661 Use of Post–Percutaneous Coronary Intervention Non-hyperemic Pressure Ratios to Guide Procedural Optimization: Cautions and Caveats	70
TCT-247 Long-Term Follow-Up of Angiographically Intermediate but Hemodynamically Nonsignificant Lesions	70
TCT-873 Biomechanical Analysis of the J-Valve Bioprosthesis: A Computed tomography–Based Computational Study	69
TCT-705 Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient S	68
TCT-845 Impact of Cerebral Embolic Protection on Perioperative Stroke in TAVR for Patients With Atrial Fibrillation	68
TCT-136 We Tested a Novel CT-Guided Algorithm for Transcatheter Aortic Valve Implantation Sizing and Placement in Patients With Severe Bicuspid Aortic Stenosis Incorporating Both Downsizing and Supra-	68
TCT-326 Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism	67
TCT-403 Intravascular Ultrasound Findings Associated With Hydrodynamic Contrast Recanalization of Coronary Chronic Total Occlusions	67
Audio Summary	66
TCT-620 Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function After Mitral Valve Transcatheter Edge-to-Edge Repair	65
TCT-247 Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement	65
TCT-17 Cross-Sectional Analysis of Disparities and Excess Vascular Mortality Associated With the COVID-19 Pandemic	65
TCT-15 National Trends, In-Hospital Mortality, and Outcomes of Atrial Septal Defect/Patent Foramen Ovale Closure Procedure: An Analysis From the National Inpatient Sample	65
TCT-157 Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety, and 1-Year Outcomes—An All-Comers Registry	64
TCT-310 Computed Tomography Coronary Angiography Guidance in Invasive Coronary Angiography: A Prospective Registry Study	64
TCT-161 Coronary Lipid Burden Early After Heart Transplantation as Assessed by Optical Coherence Tomography	63
TCT-229 Effect of Delayed Hospitalization on Patients With Non–ST-Segment Elevation Myocardial Infarction and Complex Lesions Undergoing Successful New-Generation Drug-Eluting Stent Implantation	63
LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: 1-YEAR EFFICACY AND MORTALITY OUTCOMES	63
CARDIOVASCULAR EVENTS IN PATIENTS WITH VTE: A COHORT STUDY IN REGION STOCKHOLM	62
A CASE OF WIDE COMPLEX TACHYCARDIA IN A PATIENT WITH PROPIONIC ACIDEMIA AND LONG QT SYNDROME	62
CARDIAC AMYLOIDOSIS- A WOLF IN SHEEP'S SKIN	62
BRADYCARDIA INDUCED TORSADES AND VT STORM, A WILD GOOSE CHASE	61
CAUSE OF DEATH ANALYSIS IN PATIENTS WITH INTERMEDIATE RISK ACUTE PULMONARY EMBOLISM	61
TAKAYASU'S ARTERITIS AS NON-TRADITIONAL RISK FACTOR FOR THE CARDIOVASCULAR DISORDERS - A POPULATION BASED STUDY	61
HEALTH STATUS PRESENTATION THRESHOLDS IN REAL-WORLD PERIPHERAL ARTERY DISEASE SPECIALTY CARE	61
EMBOLIZATION OF MECHANICAL AORTIC VALVE	60
THE IMPACT OF RACIAL DISPARITIES ON DIAGNOSIS AND TREATMENT OF PERIPHERAL ARTERY DISEASE	60
IMPACT OF RACE ON CLINICAL OUTCOMES IN PATIENTS WITH SECONDARY MITRAL REGURGITATION: ANALYSIS FROM THE COAPT TRIAL	60
REPRESENTATION OF WOMEN AMONG CARDIOLOGY GRAND ROUNDS SPEAKERS AT ACADEMIC CENTERS IN THE UNITED STATES	60
NATIONAL TRENDS OF MECHANICAL SUPPORT UTILIZATION DURING PERCUTANEOUS CORONARY INTERVENTIONS IN CHRONIC TOTAL OCCLUSION	60
SEX DIFFERENCES IN OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT WITH NEWER GENERATION DEVICES: A META-ANALYSIS	59
MYOCARDIAL FDG UPTAKE VARIATION AND ITS RELATIONSHIP WITH SURVIVAL DURING IMMUNOTHERAPY	58
TCTAP A-001 Prediction Model for In-Stent Restenosis After Carotid Artery Angioplasty and Stenting	57
SKIN DEEP BEFORE CHANGE OF HEART-MELANOMA CHECK POINT INHIBITOR INDUCED MYOCARDITIS	57
A NOVEL METHOD FOR IDENTIFYING DIFFUSE MYOCARDIAL ISCHEMIA DURING MENTAL STRESS PREDICTS RECURRENT HEART FAILURE IN INDIVIDUALS WITH RECENT MYOCARDIAL INFARCTION	57
TCTAP A-022 Association of Stress Hyperglycemia With Long-Term Mortality After Acute Myocardial Infarction in Patients With or Without Diabetes.	57
THE IMPORTANCE OF EARLY RECOGNITION OF DELIRIUM IN PATIENTS UNDERGOING TRANSCATHETER AORTIC AND MITRAL VALVE REPLACEMENT	56
TCTAP C-042 LAD – Diagonal Bifurcation PCI by Mini Crush Technique	56
THE IMPACT OF HYPERTENSION ON MATERNAL OUTCOME IN WOMEN WITH COARCTATION OF THE AORTA	56
HEART FAILURE IS ASSOCIATED WITH INCREASED ALL-CAUSE MORTALITY IN TRANSVENOUS LEAD EXTRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	56
CAUSE AND CIRCUMSTANCE OF VERY LATE STENT THROMBOSIS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY IN JAPANESE PATIENTS	56
COMPARISON OF ADVERSE EVENTS WITH CONTACT FORCE AND NON-CONTACT FORCE ABLATION CATHETERS: A REVIEW OF MAUDE DATABASE	56
SPONTANEOUS CORONARY ARTERY DISSECTION IS A RARE CASE OF ARRHYTHMIAS.	56
AN EXPLORATORY STUDY OF EFFECTIVENESS AND SAFETY OF RIVAROXABAN IN PATIENTS WITH LEFT VENTRICULAR THROMBUS (R-DISSOLVE)	55
IMPACT AND ASSOCIATED FACTORS ON MITRAL REGURGITATION SEVERITY IN ATRIAL FIBRILLATION PATIENTS AFTER CATHETER PULMONARY VEIN ISOLATION	55
COMPARISON AND RELIABILITY OF QT MEASUREMENTS GENERATED BY EKG MACHINES	55
EVERY ECHODENSE MASS IS NOT TISSUE- A CASE OF AN INTRA-CORONARY STENT PROTRUDING INTO THE AORTIC LUMEN	55
TCTAP C-065 A Wellen’s Syndrome: Crucial Patterns to Recognize	55
TCTAP C-074 High-Risk Coronary Intervention to the ‘Last Standing’ Left Circumflex Artery	55
TCTAP C-096 When a Stent Was Left Behind..	54
TCTAP A-042 An Umbrella Review of the Meta Analyses About Risk and Protective Factors for Post-discharge Bleeding Events in Percutaneous Coronary Intervention Setting	54
TCTAP C-059 A Hard Decision and the Only Option : Provisional LM Stenting in Very Calcified Vessel	54
TCTAP A-039 On-Pump and Off-Pump Coronary Artery Bypass Grafting on 10-Year Mortality Versus Percutaneous Coronary Intervention	54
TCTAP C-099 Double Trouble ! Coronary Dissection by Balloon Rupture Followed by Stuck IVUS After Stenting in a Rotational Atherectomy Case	54
TCTAP C-077 Antegrade Approach Strategy for Left Main CTO Lesion	54
A BABY SO ADORABLE MY HEART CANTU HELP BUT STOP: A CASE OF PERIPARTUM COMPLETE HEART BLOCK WITH GENETIC PREDISPOSITION	54
TCTAP A-086 Can a Machine Learning Based Approach Improve Risk Prediction and Individualise Decision Making Between Percutaneous and Surgical Revascularisation in Patients With Complex Coronary Artery	54
IVC STENT CAUSING RIGHT ATRIAL(RA)-AORTIC(AO) FISTULA	53
TCTAP C-139 A Unique Case of in Stents Restenosis: The Rings of Fire	53
ASSOCIATION OF PROGNOSTIC NUTRITIONAL INDEX AND DIABETES WITH PROGNOSIS OF CORONARY ARTERY DISEASE	53
TCT-81 Absolute Zero-Contrast Percutaneous Coronary Intervention Under Intravascular Ultrasound Guidance in Patients With Chronic Kidney Disease: From Despair to Hope?	53
EOSINOPHILIC MYOCARDITIS IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANCA ASSCOCIATED VASCULITIS OVERLAP	53
METABOLIC SIGNATURES OF CARDIAC DYSFUNCTION ARE ASSOCIATED WITH MULTIMORBIDITY AND POST-TRANSCATHETER AORTIC VALVE IMPLANTATION MORTALITY	53
TCTAP C-142 A Challenging Case of Simultaneous Transarterial Coil Embolization in the Treatment of Post-EVAR Endoleak	53
CARDIAC SEQUELAE OF LONG-COVID	53
WHOM TO BELIEVE? POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY AND NEAR-INFRARED SPECTROSCOPY INTRAVASCULAR ULTRASOUND IMAGING IN VULNERABLE CORONARY PLAQUE DETECTION	52
IMPACT OF SACUBITRIL/VALSARTAN ON CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION USING REAL-WORLD DATA: A SYSTEMATIC REVIEW AND META-ANALYSIS	52
TCT-181 Effect of Lipoprotein(a) in Patients With Coronary Calcification Undergoing Percutaneous Coronary Intervention	52
HEMODYNAMICS IN CONSTRICTIVE PERICARDITIS	52
DRIVERS OF VARIATION IN TELEMEDICINE USE AT AN ACADEMIC CARDIOVASCULAR CENTER DURING THE COVID-19 PANDEMIC	52
PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19	51
LONG TERM CMR CHARACTERIZATION OF ATHLETES RECOVERING FROM COVID-19 INFECTION AND RETURN TO PLAY	51
APPLICATION OF ACC/AHA 2020 HEART FAILURE CLINICAL PERFORMANCE AND QUALITY MEASURES FOR ADULTS WITH HEART FAILURE IN A MIDDLE-INCOME-NATION	51
TCT-189 The Efficacy and Safety of an Adjunctive Transcoronary Pacing Strategy During Rotational Atherectomy: The Results of the Strategy to Rotablate and PACE (ROTA-PACE) Study	51
TCT-112 Repeat Revascularization Impact on 10-Year Survival After PCI or CABG: Post Hoc Analysis of the SYNTAXES Trial	50
TCT-199 A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial	50
STRAIN IMAGING AS AN EARLY PROGNOSTIC INDICATOR FOR LATE COMPLICATIONS IN COVID-19 PATIENTS	50
USING ARTIFICIAL INTELLIGENCE TO EVALUATE ADDED VALUE OF CORONARY ARTERY CALCIUM SCORING FROM STANDARD AND LOW-DOSE UNGATED CT IN MYOCARDIAL PERFUSION PET/CT IMAGING MORTALITY RISK ASSESSMENT	50
VENOUS THROMBOEMBOLISM IN HOSPITALISED COVID PATIENTS: AN UMBRELLA REVIEW	50
ECHOCARDIOGRAPHY-BASED CONVOLUTIONAL NEURAL NETWORK ACCURATELY DIFFERENTIATES ETIOLOGIES OF INCREASED LEFT VENTRICULAR WALL THICKNESS	50